Can the antifungal nystatin cause cardiac palpitations?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Nystatin Cause Palpitations?

Nystatin can cause tachycardia (rapid heart rate), which patients may perceive as palpitations, though this adverse effect is rare. 1

Evidence from FDA Drug Labeling

The official FDA prescribing information for oral nystatin explicitly lists tachycardia among the rarely reported adverse reactions. 1 Other cardiovascular manifestations documented in the drug label include:

  • Tachycardia has been reported as a rare adverse effect of nystatin therapy 1
  • The drug is otherwise well tolerated even with prolonged use 1
  • Most adverse effects involve gastrointestinal symptoms (diarrhea, nausea, vomiting) rather than cardiac manifestations 1

Experimental Cardiac Effects

While oral nystatin rarely causes clinically significant cardiac effects in humans, experimental research demonstrates that nystatin can have direct cardiac effects at high concentrations:

  • Intravenous nystatin at 4 mg/kg caused heart failure in intact rats, and at lower concentrations (10-25 mcg/mL) induced arrhythmias in cultured rat myocardial cells 2
  • These arrhythmias could be minimized by elevated potassium and magnesium concentrations 2
  • Nystatin increases myocardial cell membrane rigidity, which correlates with the biological cardiac changes observed 2

Clinical Context and Reassurance

The key distinction is that oral nystatin is poorly absorbed systemically, which explains why cardiac effects are rare in clinical practice despite the drug's potential for cardiac toxicity at high systemic concentrations:

  • Oral nystatin is not significantly absorbed from the gastrointestinal tract, limiting systemic exposure 1
  • Even oral overdoses exceeding 5 million units daily primarily cause gastrointestinal upset rather than cardiac toxicity 1
  • The tachycardia reported in the FDA label likely represents idiosyncratic reactions or hypersensitivity phenomena rather than direct cardiac toxicity 1

Common Pitfalls to Avoid

  • Do not confuse the experimental cardiac toxicity seen with intravenous nystatin in animal models with the clinical safety profile of oral nystatin 2
  • Do not dismiss patient reports of palpitations, as tachycardia is a documented (though rare) adverse effect 1
  • Consider alternative causes of palpitations in patients taking nystatin, as the underlying fungal infection, concurrent medications, or other medical conditions are more likely culprits than the nystatin itself 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.